TIDES Europe 2026

03rd November 2026 - 05th November 2026

Join TIDES Europe 2026, Europe’s biggest event for oligonucleotides, peptides, mRNA, and drug delivery, from November 3-5 in Amsterdam. Meet with 900+ industry experts, gain insights from 100+ expert speakers, explore 90+ exhibitors, and attend immersive workshops.

Discover cutting-edge strategies in discovery, development, and manufacturing to accelerate therapeutics to market. Save 10% at checkout using “BioPharmaAsia10”.

Advanced Therapies USA 2026

04th November 2026 - 05th November 2026

The Advanced Therapies Congress is America’s most exciting cell and gene therapy conference and exhibition.

The conference brings together a community of 1,200 global executives at the Hynes Convention Center, Boston, to be inspired by 200 speakers and 50 start-ups over 2 incredible days.

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.

Cell & Gene Therapy International Europe 2026

03rd November 2026 - 05th November 2026

Join Cell & Gene Therapy International Europe 2026 from 3-5 November at Hotel Palace Berlin to explore the future of advanced therapies.

This premier event brings together 300+ global experts to address the industry’s most pressing challenges: scaling manufacturing, reducing costs, and accelerating regulatory pathways.

Discover breakthrough innovations across autologous, allogeneic, and AAV therapies while gaining actionable insights from industry leaders at Novartis, Johnson & Johnson, UCB Pharma, and more.

Explore smart manufacturing technologies including AI, automation, and next-generation analytics that are transforming production efficiency. Your registration includes full access to two co-located events—Exosomes Europe and LNP Delivery—plus live lab demos, investor panels, and exclusive networking opportunities.

Whether you’re in R&D, manufacturing, regulatory affairs, or investment, this is where theory meets industrial reality.

3rd Annual TRP Target Selection & Drug Design Summit 2026

03rd November 2026 - 05th November 2026

As radiopharmaceutical pipelines continue to expand, identifying and validating the right targets has become one of the most critical factors for clinical and commercial success.

The 3rd Annual TRP Target Selection & Drug Design Summit brings together leading experts across discovery biology, medicinal chemistry, radiochemistry, translational science, toxicology, and dosimetry to share strategies for advancing next-generation radiopharmaceuticals.

Attendees will gain insights into novel target identification, target validation, radionuclide selection, preclinical development, and safety optimization.

Through scientific presentations, interactive discussions, and dedicated networking opportunities, this meeting provides a unique platform for researchers and developers to overcome key challenges and accelerate the progression of innovative radiopharmaceutical therapies toward the clinic.

3rd ADC Payload Summit 2026

04th November 2026 - 06th November 2026

The 3rd ADC Payload Summit is the only industry-led meeting dedicated exclusively to advancing ADC payload innovation.

Taking place November 4-6, 2026, in Boston, the summit will bring together 70+ experts across payload discovery, medicinal chemistry, biology, translational science, toxicology, and ADC development to address the key challenges shaping the future of antibody-drug conjugates.

Attendees will gain insights into novel payload mechanisms, dual-payload ADC strategies, resistance biology, therapeutic index optimization, and clinical translation from leading organizations including AstraZeneca, AbbVie, GSK, Takeda, GeneQuantum Healthcare, Hexagon Bio, and Callio Therapeutics, while building valuable connections with peers driving the next generation of ADC innovation.

Global RESCON Summit 2026

10th November 2026 - 11th November 2026

The Global RESCON Summit is a prestigious and highly anticipated event, building on the success of previous editions in New York, Porto, Barcelona, and San Francisco.

Dedicated to Inhalation & Respiratory Drug Delivery | Connected Devices, the summit brings together world-leading experts from the pharmaceutical and biotechnology sectors, device manufacturers, material innovators, and academia.

BIO-Europe 2026

09th November 2026 - 11th November 2026

The premier global biopharma partnering event unveils a bold new vision for its 32nd annual conference in Cologne, Germany, November 9-11, 2026.

BIO-Europe is evolving beyond Europe’s largest partnering event to become the neutral forum where the biopharma C-suite shapes partnerships and industry strategy worldwide.

As the sector faces increasing complexity across regulation, clinical development, manufacturing, policy, and financing, the 2026 conference expands to convene C-level executives through seven integrated tracks and high-impact plenary sessions.

The enhanced programme delivers strategy-focused content spanning regulatory, clinical, manufacturing, dealmaking, therapeutic areas, and ecosystem streams, fuelling dialogue among decision-makers across the global life sciences value chain.

11th Microbiome Movement USA Summit 2026

09th November 2026 - 11th November 2026

The 11th Microbiome Movement USA Summit is the leading industry forum dedicated to advancing microbiome-based therapeutics from scientific discovery to clinical and commercial success.

Bringing together senior leaders from biopharma, biotech, investment, regulatory, and academic organizations, the meeting will explore how to demonstrate clinical efficacy, navigate evolving regulatory expectations, strengthen manufacturing strategies, and rebuild investor confidence in the microbiome field.

Join experts from organizations including Ferring Pharmaceuticals, Vedanta Biosciences, Nestlé Health Science, MRM Health, and The Gates Foundation to shape the future of live biotherapeutics and microbiome innovation.

Download the full event guide to learn more about the agenda, speakers, networking opportunities, and how you can get involved.

Extractables & Leachables Europe 2026

09th November 2026 - 11th November 2026

Europe’s leading conference dedicated to the science, testing, and regulatory landscape of extractables and leachables (E&L) in pharmaceuticals and medical devices.

Organised by Smithers, this event brings together CEOs, senior scientists, toxicologists, and R&D leaders from across the E&L supply chain.

Key 2026 themes include AI and digital transformation in E&L, advanced analytical chemistry, toxicological risk assessment, single-use systems, and medical device combination products.

With pre-conference workshops on 9 November and a two-day main programme, attendees gain the latest insights, regulatory updates, and networking.

Register with code BIOPHARMA10 for 10% off.

9th RNA-Targeted Drug Discovery & Development Summit 2026

10th November 2026 - 12th November 2026

The 9th RNA-Targeted Drug Discovery & Development Summit is the industry’s only dedicated forum focused exclusively on advancing RNA-targeted small molecules.

Taking place in Boston on November 10–12, 2026, the summit will unite 80+ leaders from biotech, pharma and academia to explore the latest breakthroughs in RNA target selection, structure-guided design, direct RNA binding, splice modulation, RNA degradation and translational development.

Featuring expert speakers from organizations including PTC Therapeutics, AstraZeneca, Sanofi, ReviR Therapeutics and Remix Therapeutics, the event provides a unique platform to share data, tackle discovery challenges and accelerate the development of next-generation RNA-targeted medicines.

 2nd World RNA-Based Therapeutic & Vaccine Summit South Korea 2026

10th November 2026 - 12th November 2026

Driven by South Korea’s government making strategic investments in mRNA platforms and growing collaboration between global pharma and local biotech innovators, the field is experiencing renewed development momentum. This is placing the region as a key hotspot for global mRNA innovation and interest.

Uniquely positioned as the industry’s most comprehensive biopharma forum, the 2nd World RNA-Based Therapeutic & Vaccine Summit South Korea brings together global and local leaders to share first-hand insights into cutting-edge mRNA modalities, delivery technologies, and manufacturing excellence, to progress mRNA medicines to patients faster.

Join 90 leading players from large pharma including Sanofi, Eisai, and Meiji Seika Pharma to brand new biotechs such as Lemonex Bio, AceRNA Technologies, and BreezeBio to build future collaborations.

Global Biotechnology Summit 2026

11th November 2026 - 12th November 2026

Description: Global Biotech Summit is the UAE’s premier platform for biotechnology, life sciences, and healthcare innovation, bringing together global leaders, scientists, investors, policymakers, startups, and industry pioneers to shape the future of the sector.

Taking place on 11–12 November 2026 at ADNEC Marina, Abu Dhabi, the summit fosters collaboration, investment, and knowledge exchange across emerging areas including biopharmaceuticals, precision medicine, AI-driven drug discovery, cell and gene therapy, diagnostics, digital health, and biomanufacturing.

Through high-impact conferences, a world-class exhibition, startup showcases, and strategic networking opportunities, Global Biotech Summit accelerates partnerships, innovation, and commercialization across the regional and global biotechnology ecosystem.

Revive ME 2026

11th November 2026 - 12th November 2026

Revive ME is the Middle East’s premier global longevity and health technology summit, bringing together 2,000+ changemakers, 700+ global and regional brands, 500+ C-suite and senior leaders, 150+ exhibitors and sponsors, and 50+ media and supporting partners in Abu Dhabi.

Taking place on 11–12 November 2026 at ADNEC Marina, the event serves as a platform for healthcare leaders, researchers, innovators, investors, policymakers, and entrepreneurs to connect, collaborate, and accelerate the future of longevity.

Through thought-provoking discussions, breakthrough technologies, strategic partnerships, and networking opportunities, Revive ME is where the global longevity ecosystem comes together to shape the future of healthier, longer lives.

9th Lab Asset & Facility Management Summit 2026

10th November 2026 - 12th November 2026

As budgets tighten and scientific complexity grows, lab operations, facilities, asset management, engineering, and EHS leaders face increasing pressure to improve efficiency while accelerating research.

Returning to Boston, the 9th Lab Asset & Facility Management Summit is the only forum dedicated to the operational functions that enable science to happen.

Join 190+ senior leaders to explore practical strategies for optimizing asset performance, streamlining lab environments, strengthening cross-functional collaboration, and maximizing time back to science.

Through interactive discussions, real-world case studies, and peer-to-peer networking, you’ll gain actionable insights to build smarter, more resilient, and efficient research environments that support scientific innovation.

LSX Investival Showcase London 2026

16th November 2026 - 16th November 2026

LSX Investival Showcase London brings together biotech innovators, medtech pioneers, healthcare investors and corporate strategists from across Europe and beyond, creating a dynamic environment for investment discussions, partnering opportunities and business development.

For life science companies, the Investival Showcase London offers a valuable opportunity to build visibility with European and global market, pitch to active investors and build new connections through organised partnering and networking opportunities.

Taking place on the first day of London Life Science Week, it’s growing in size and scale. It’s the first and largest public event of the week, open to the wider life science community, and offers full partnering facilities to all attendees.

Biomarker Operations & Biospecimen Management Summit 2026

16th November 2026 - 17th November 2026

Standardize & Scale Biomarker Operations Across Increasingly Complex Trials to Prevent Critical Delays & Keep Studies On Track

For the very first time, the biomarker and biospecimen management community will have a forum solely dedicated to this rapidly expanding and increasingly critical function.

As trials expand globally and become more sample-intensive, protecting sample integrity and turning specimen data into trustworthy decisions has never mattered more. The inaugural Biomarker Operations & Biospecimen Management Summit provides a long-overdue home to share experiences and define the standards this field now demands.

Following the complete sample lifecycle, from kit design and site collection through to tracking, storage, biobanking, lab coordination, and data harmonization, attendees will gain practical insights to implement robust, scalable biomarker and biospecimen operations.

Join 80+ senior leaders from biopharma, labs, CROs, and biobanks united in ensuring every sample is treated with the precision, rigor, and care it requires.

Event Dates: November 16-17, 2026

Event Location: Hyatt Regency, One Ave de Lafayette, Boston, MA.

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma 2026

16th November 2026 - 17th November 2026

The Marcus Evans AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma conference explores how pharma leaders are embedding Gen AI for long-term forecasting, Agentic AI for Real-World Evidence, and advanced analytics into cross-functional workflows, all under strong data and AI governance.

Through case studies, panels, roundtables, and workshops, attendees will gain practical insights on rare disease and lifecycle forecasting, scenario planning, forecasting agility in volatile therapy markets, healthcare data governance, and structuring enterprise AI and analytics functions.

Speakers include senior leaders from Novartis, UCB, BioMarin, CSL, Ferring Pharmaceuticals, Lundbeck, and many more of the most prestigious pharmaceutical companies.

BioPharmaAsia readers can benefit from a €200 discount! Enquire in our website for more registration information.

4th LNP Characterization & Analytical Development Summit 2026

18th November 2026 - 19th November 2026

The 4th LNP Characterization & Analytical Development Summit is the only industry-focused event dedicated to advancing the analytical and characterization capabilities needed to support the next generation of lipid nanoparticle (LNP)-enabled therapeutics.

Bringing together analytical development, characterization, formulation, and CMC leaders from across pharma and biotech, the meeting will explore innovative approaches to structural characterization, predictive critical quality attributes (CQAs), targeted LNP analytics, multi-attribute methods, and complex payload systems.

Through expert-led case studies, interactive discussions, poster presentations, and networking opportunities, attendees will gain practical insights to improve product quality, accelerate development timelines, and meet evolving regulatory expectations.

10th American Pharma Manufacturing & Outsourcing Summit 2026

19th November 2026 - 20th November 2026

The American Pharma Manufacturing & Outsourcing Summit is taking place November 19-20, 2026, in Boston, MA.

This pharma manufacturing and pharma outsourcing conference is designed to provide pharmaceutical executives with current trends, strategic insights, and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics.

This event brings together manufacturing and supply chain-focused leaders involved in pharmaceutical manufacturing and outsourcing.

Network with over 150 of your fellow pharma leaders as we explore strategies to maximize efficiency while remaining compliant in this ever-evolving environment.

Pharma Logistics & SCM Summit 2026

23rd November 2026 - 24th November 2026

Pharma Logistics & SCM Summit 2026 brings together pharmaceutical supply chain, logistics, distribution, quality, operations, and compliance leaders building more resilient pharma supply chains.

The event focuses on end-to-end visibility, risk management, regulatory compliance, digital supply chain tools, serialization, demand planning, distribution excellence, and global supply chain optimization.

Engage with 500+ senior pharma professionals, 135+ sessions, 72+ real-world case studies, solution providers, and expert speakers in Berlin this October

Pharma Packaging & Labeling Summit 2026

23rd November 2026 - 24th November 2026

Pharma Packaging & Labeling Summit 2026 brings together packaging, labeling, artwork, regulatory, quality, serialization, and supply chain professionals focused on compliance and patient safety.

The event focuses on labeling accuracy, artwork management, serialization, anti-counterfeiting, smart packaging, sustainability, regulatory compliance, digital workflows, and packaging innovation.

Engage with 500+ senior pharma professionals, 135+ sessions, 72+ real-world case studies, solution providers, and expert speakers in Berlin this October.

Pharma Cold Chain Summit 2026

23rd November 2026 - 24th November 2026

Pharma Cold Chain Summit 2026 brings together cold chain, logistics, supply chain, quality, packaging, and distribution professionals protecting temperature-sensitive pharmaceutical products.

The event focuses on real-time temperature monitoring, cold chain visibility, regulatory compliance, data-driven risk management, biologics, advanced therapies, ultra-low temperature logistics, and packaging innovation.

Engage with 500+ senior pharma professionals, 135+ sessions, 72+ real-world case studies, solution providers, and expert speakers in Berlin this October.

Pharma TRACKTS 2026

23rd November 2026 - 24th November 2026

Pharma TRACKTS 2026 brings together track & trace, serialization, packaging, labeling, compliance, supply chain security, and digital transformation professionals.

The event focuses on serialization, aggregation, anti-counterfeiting, digital product passports, regulatory updates, data exchange, product authentication, supply chain visibility, and advanced tracking technologies.

Engage with 500+ senior pharma professionals, 135+ sessions, 72+ real-world case studies, solution providers, and expert speakers in Berlin this October.

Pharma Flow Europe 2026

23rd November 2026 - 24th November 2026

Pharma Logistics & SCM Summit 2026, Pharma Packaging & Labelling Summit 2026, Pharma Cold Chain Summit 2026, and Pharma TRACKTS 2026 come together as one powerful pharma supply chain, packaging, cold chain, and traceability platform, taking place on November 23–24, 2026, at the Radisson Blu Hotel Frankfurt.

The co-located show brings together senior leaders from pharmaceutical logistics, supply chain management, packaging, labelling, cold chain, distribution, quality, regulatory affairs, serialisation, track & trace, and compliance.

The event focuses on supply chain visibility, temperature-controlled logistics, packaging innovation, labelling accuracy, serialization, aggregation, anti-counterfeiting, regulatory compliance, product integrity, and end-to-end pharmatraceability.

Engage with senior pharma professionals, solution providers, and expert speakers in Frankfurt this November. Register with code MKT10 to receive a 10% discount.

PharmaLab Congress and Exhibition 2026 at a new venue

23rd November 2026 - 25th November 2026

PharmaLab Congress and Exhibition will take place from 23–25 November 2026 at the darmstadtium in Darmstadt near Frankfurt Airport, a modern conference centre with state-of-the-art and sustainable technical facilities.

The event for all pharmaceutical laboratory sectors will cover various topics and lectures on analytics, bioanalytics and microbiology, providing opportunities to share knowledge and experience with regulators, industry experts and laboratory scientists.

Participants benefit from 9 parallel conferences, 3 pre-conference workshops, over 100 presentations, more than 60 exhibitors and the networking event.

Continue reading to find out more….

5th European Biomanufacturing Summit 2026

24th November 2026 - 25th November 2026

The European Biomanufacturing Summit is taking place November 24-25, 2026 in Dusseldorf, Germany.

The event is designed to provide biopharmaceutical and biomanufacturing executives with current trends in biotechnology and pharmaceuticals, advances in cell and gene therapy, and CMC pharmaceutical development.

The strategic insights regarding biotechnological developments, best practices in manufacturing, drug delivery, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics are among the topics that will be covered.

Novel CNS Biomarkers Summit Europe 2026

30th November 2026 - 02nd December 2026

The Novel CNS Biomarkers Summit Europe is the only European meeting dedicated exclusively to advancing fluid, imaging, and digital biomarkers for CNS drug development.

Bringing together biomarker, translational medicine, neuroscience, and clinical development leaders, the summit focuses on accelerating the discovery, validation, and implementation of next-generation biomarkers across neurodegenerative and neurological diseases.

Why Attend?

• Join 60+ biomarker and translational medicine leaders

• Gain insights from 17+ expert speakers

• Explore biomarker strategies across 6+ CNS indications

• Participate in interactive workshops and networking opportunities

• Learn from leading organisations including Roche, UCB, Lundbeck, Servier, and more

4th Cell Therapy for Autoimmune Disease Summit 2026

01st December 2026 - 03rd December 2026

Join the 4th Cell Therapy for Autoimmune Disease Summit, the leading industry forum dedicated to advancing next-generation cell therapies for autoimmune diseases.

Bringing together biotech, pharma, academic, and clinical leaders, this meeting explores the latest developments across CAR-T, Treg, NK, MSC, and emerging in vivo cell therapies.

Gain exclusive insights into clinical readouts, immune reset strategies, translational research, patient selection, manufacturing scalability, and commercialization pathways.

With expert speakers from leading innovators and dedicated tracks covering preclinical and clinical development, this is the essential event for those shaping the future of autoimmune cell therapy and immune-mediated disease treatment.

10th Anniversary Antifibrotic Drug Development Summit 2026

01st December 2026 - 03rd December 2026

The 10th Anniversary Antifibrotic Drug Development Summit returns to Boston as the only industry-focused forum dedicated to cross-indication antifibrotic drug development.

Bringing together 60+ senior leaders across discovery, preclinical, translational, biomarker, and early clinical development, the meeting explores how shared fibrosis mechanisms can accelerate innovation across organs and indications.

Through three interactive workshops and two conference days, attendees will examine fibrosis resolution, cross-tissue biology, human-relevant models, predictive biomarkers, patient stratification, and indication expansion strategies.

Join experts from leading organizations including AbbVie, Madrigal Pharmaceuticals, Arda Therapeutics, aTyr Pharma, and Vicore Pharma to gain practical insights, valuable connections, and confidence in advancing next-generation antifibrotic therapies.

Amylin-Based Therapeutics Summit 2026

01st December 2026 - 03rd December 2026

The inaugural Amylin‑Based Therapeutics Summit 2026 is the first and only industry‑dedicated forum bringing biopharma and academia together to dive deep and explore the full breadth of amylin drug development – from foundational receptor biology to late‑stage clinical strategy.

Across two immersive days, learn from and connect with pioneering minds from Novo Nordisk, Eli Lilly, Zealand Pharma, iBio, I2O Therapeutics and emerging innovators who are collectively shaping the field.

Continue reading for the full event guide

8th CNS Drug Delivery Summit 2026

01st December 2026 - 03rd December 2026

Long regarded as one of the greatest barriers to successful CNS drug development, brain delivery is entering a new era of clinical validation. Following FDA approval of Denali’s Avlayah and encouraging progress from Roche’s Trontinemab, the industry now has proof that blood-brain barrier (BBB) shuttle technologies can achieve meaningful CNS exposure for biologics.

This momentum is driving innovation across brain shuttles, targeted vectors, oligonucleotide delivery, focused ultrasound, intrathecal systems, and next-generation delivery platforms.

Despite this progress, key challenges remain, including improving brain exposure, demonstrating clinical translatability, optimising biodistribution, reducing toxicity risk, and scaling manufacturing.

As developers move beyond transferrin receptor targeting and explore novel BBB receptors, advanced imaging, humanised models, and innovative delivery approaches, collaboration is critical.

The 8th CNS Drug Delivery Summit brings together 100+ senior leaders across neuroscience, drug delivery, translational science, biologics, platform development, business development, and investment to accelerate the next generation of CNS therapeutics.

15th Tumour Models Summit London 2026

02nd December 2026 - 03rd December 2026

The 15th Tumour Models Summit London is Europe’s longest-standing and most comprehensive meeting dedicated to advancing preclinical and translational tumour modelling.

As oncology pipelines become increasingly dependent on immunotherapies, cell therapies, ADCs, radioligand therapies, and precision medicines, development teams face growing pressure to improve translational confidence, identify predictive models, and generate decision-grade evidence earlier in development.

Join leaders from Roche, AstraZeneca, Johnson & Johnson, Eli Lilly, Immunocore, Merck, Molecular Partners, ImmunoKey, and innovative oncology biotechs to explore how human-relevant models, NAMs, AI-enabled approaches, patient-derived systems, biomarkers, tumour microenvironment models, and integrated development strategies can improve candidate selection, predict clinical outcomes, and reduce late-stage attrition.

Whether your focus is model validation, safety prediction, tumour microenvironment biology, translational biomarkers, AI-driven prediction, or regulatory strategy, this is the industry’s definitive forum for improving oncology model translatability.

3rd Annual Personalized Cancer Vaccine Summit 2026

01st December 2026 - 03rd December 2026

The personalized cancer vaccine field has reached a defining milestone. With Moderna and Merck reporting positive initial Phase 3 data for intismeran autogene in combination with Keytruda, the first regulatory approval of a personalized neoantigen cancer vaccine is now firmly within sight, accelerating momentum across the entire industry.

Yet significant challenges remain. As innovation accelerates, organizations must overcome key challenges spanning development, manufacturing, delivery, and market access.

The 3rd Annual Personalized Cancer Vaccine Summit brings together leaders from across Moderna, Medici Therapeutics, Geneos Therapeutics, Nykode Therapeutics, Echo Immune, HDT Bio, Mayo Clinic, Transgene, and more, to share data-driven insights, benchmark strategies and forge long-term partnerships for driving personalized cancer vaccines closer to approval.

8th Cell & Gene Therapy Analytical Development Summit 2026

01st December 2026 - 03rd December 2026

The 8^th Cell & Gene Therapy Analytical Development Summit is the leading forum for analytical development, quality control, assay development, and CMC professionals working across advanced therapies.

Bringing together experts from biotech, pharma, and academia, the summit explores the latest strategies to ensure product quality, potency, safety, and consistency throughout development and commercialization.

For the first time, the event unites both cell and gene therapy analytical communities under one roof, creating unrivalled opportunities to benchmark approaches, solve shared challenges, and build valuable connections.

Through dedicated cell and gene therapy tracks, attendees will gain practical insights into analytical characterization, potency testing, regulatory expectations, novel technologies, and emerging industry challenges, helping accelerate the delivery of safe and effective therapies to patients.

13th Digital Pathology and AI Congress: Europe 2026

09th December 2026 - 10th December 2026

The 13th Digital Pathology and AI Congress: Europe 2026

The advances and applications of digital pathology; artificial intelligence and machine learning for primary diagnosis and clinical research

Date: 9th Dec 2026 to 10 Dec 2026

10th Complement-Based Drug Development Summit 2026

08th December 2026 - 10th December 2026

The 10th Complement-Based Drug Development Summit is the leading industry forum dedicated to advancing complement biology and therapeutic development.

The meeting brings together biopharma leaders, emerging biotech innovators, translational scientists, clinicians, and academic researchers to explore new opportunities across rare disease, inflammation, autoimmune disorders, nephrology, ophthalmology, neurology, and hematology.

Why Attend?

• Network with 80+ industry experts

• Learn from 25+ leading speakers

• Explore end-to-end complement drug development strategies

• Gain insights from 18+ data-driven presentations
• Participate in focused workshops and scientific discussions
• Learn from leading organizations including Regeneron, Genentech, Sanofi, Apellis and more.

World CNS Summit South Korea 2026

08th December 2026 - 10th December 2026

Korea is rapidly emerging as a global hub for CNS innovation, with breakthroughs spanning novel modalities, BBB shuttle technologies, and differentiated targets beyond Aβ and tau.

This momentum has attracted growing interest from pharma and investors alike, with major partnerships in 2026 including Fosun & AriBio, Insilico & SK Biopharmaceuticals, and Johnson & Johnson & Prazer Therapeutics, underscoring the significant opportunity to translate promising Korean assets into successful disease-modifying CNS therapies.

Against this backdrop of accelerating investment and innovation, the World CNS Summit South Korea will bring together leading Korean innovators including ABL Bio, AriBio, and ADEL, alongside global industry leaders such as Eli Lilly, Lundbeck, JCR Pharmaceuticals, and Novartis, to exchange insights, forge strategic partnerships, and advance the next generation of disease-modifying therapies for neurological disorders.

3rd Obesity & Weight Loss Drug Development Summit West 2026

09th December 2026 - 10th December 2026

Optimizing Tolerability, Quality of Weight Loss & Personalized Therapies to Drive Competitive Drug Development

As obesity drug development enters a defining new chapter, the race is no longer about developing the next GLP-1, but delivering the next breakthrough in tolerability, muscle preservation, patient adherence, precision medicine, and long-term outcomes.

With hundreds of obesity assets in development and billions invested in the space, 2026 is a pivotal moment for companies to differentiate their pipelines and benchmark their strategies.

The 3rd Obesity & Weight Loss Drug Development Summit West is where pharma and biotech leaders come together to answer the questions shaping the next decade of obesity therapeutics. This summit is dedicated to the practical challenges and strategic decisions driving drug development success.

Bringing together 80+ senior executives and decision-makers, this intimate forum offers opportunities to exchange insights, build meaningful partnerships, and understand what today’s innovation really means for tomorrow’s therapies.

Rational Based Drug Design Summit Europe 2027

13th January 2027 - 14th January 2027

The Rational Based Drug Design Summit Europe is the dedicated meeting bringing together structural biologists, biophysicists, medicinal chemists, computational chemists, AI drug discovery specialists and drug discovery leaders committed to advancing next-generation therapeutics.

Taking place on 13-14 January 2027 in Amsterdam, join Europe’s leading biopharma organisations to explore how structural biology, biophysics, medicinal chemistry and AI are being integrated to improve target identification, molecular design, hit validation and candidate selection.

Through scientific presentations, real-world case studies, interactive discussions and dedicated networking opportunities, gain practical insights into reducing development risk, accelerating discovery timelines and tackling challenging therapeutic targets.

Don’t miss the opportunity to connect with Europe’s foremost drug discovery innovators and help shape the next generation of rational drug design.

5th Ophthalmic Drug Delivery Summit 2027

19th January 2027 - 21st January 2027

The 5th Ophthalmic Drug Delivery Summit is where the innovators behind the next generation of ocular therapies come together to solve one critical challenge: getting the right therapy to the right place in the eye.

Hear directly from leaders at Kodiak Sciences, Re-Vana Therapeutics, Ripple Therapeutics, Eli Lilly, Genentech, Sanofi, Astellas, Apellis, Beacon Therapeutics, Kriya Therapeutics and more as they share the latest thinking on long-acting therapies, novel delivery routes, gene and cell therapy, translational science and drug-device integration.

Explore how methods to extend ocular exposure through, progress innovative techniques to progress sustained delivery and sustained-release implants through conventional intravitreal injection.

Expect candid lessons, emerging strategies and cross-functional perspectives spanning delivery, formulation, devices, CMC, clinical development, regulatory strategy and commercialization.

Advanced Therapies Week 2027

18th January 2027 - 21st January 2027

Advanced Therapies Week 2027 will take place in San Diego, California, from 18–21 January 2027, bringing together the global cell and gene therapy community for four days of insight, innovation and high-value networking.

Organised by Phacilitate, the event connects biotech and pharma leaders, therapy developers, investors, CDMOs, solution providers and other key stakeholders across the advanced therapies ecosystem.

Through expert-led sessions, strategic partnering opportunities and dynamic discussions, attendees will explore the latest developments shaping the future of cell and gene therapy, from research and clinical development to manufacturing, commercialisation and patient access.

Advanced Therapies Week provides a platform to build partnerships, exchange ideas and accelerate the development of transformative therapies for patients worldwide.

Register with ‘BIOPH20’ to get 20% off tickets.

PharmaMarketing Summit 2027

21st January 2027 - 22nd January 2027

The PharmaMarketing Summit returns on January 21-22, 2027, at the Four Seasons Hotel Westlake Village, California, bringing together America’s foremost pharmaceutical commercial leaders to redefine brand performance in the AI era.

Senior executives, including Anthony Pugliese, Vice President of Obesity Intelligence & Analytics at Amgen, Sonia Thomas, Head of Marketing Strategy & Transformation at Conexeu Sciences Inc., and Jeremy Whitelock, Vice President of Global Value and Access at Kailera Therapeutics, will share proven frameworks for launch excellence, HCP engagement, and market access strategy.

This invitation-only gathering offers an unmatched environment for peer exchange and strategic alliance building. Secure your place at the forefront of pharma marketing innovation today.

Find out more about the summit here:

Muscular Disorders Drug Development Summit 2027

26th January 2027 - 28th January 2027

After a year marked by uncertainty around Sarepta’s Elevidys, the field is on the verge of new era shaped by cross-modality innovation and meaningful progress, with FDA submissions anticipated from Regenxbio, Capricor and Avidity that could transform therapeutic options for muscular dystrophies.

With investments including Servier’s $2.65 billion buyout of Edgewise signposting reignited pharma interest and funding opportunities, muscle disease drug developers are poised to double down on investments across their preclinical, translational and clinical programs in 2026 and beyond.

Take advantage of this timely opportunity to join 60+ industry experts spanning muscle disease biology, translation, clinical development and more at the Muscular Disorders Drug Development Summit for three days of focused collaboration designed to:

• Explore emerging modalities beyond gene therapy

• Discover lessons learnt from developers of approved drugs

• Enhance biomarker measurements of muscular function and activity

• Innovate more targeted delivery to specific muscles while avoiding off-target tissues
• Leverage real-world data to uncover patient-relevant endpoints

With momentum building, don’t miss your chance to learn from Servier, Dyne Therapeutics, Sanofi, Biogen, Avidity Biosciences and more at the only forum dedicated to addressing biopharma’s most pressing challenges in advancing novel therapies for muscular dystrophies, Pompe disease and related myopathies.

2nd Non-Opioid Pain Therapeutics Summit 2027

26th January 2027 - 28th January 2027

One year after JOURNAVX® became the first new class of pain medicine approved in decades, momentum across the non-opioid pain landscape continues to accelerate, driving significant scientific, clinical, and investment activity.

The 2nd Non-Opioid Pain Therapeutics Summit will unite leaders in pain biology, drug discovery, translational science, clinical development, medical affairs, and business development to examine how emerging mechanisms can be translated into effective therapies across acute and chronic pain indications.

Discussions will focus on human-relevant translational models, target and biomarker validation, clinical trial optimization, placebo response mitigation, and identifying investable assets.

Experts from Vertex Pharmaceuticals, Eli Lilly, AbbVie, Grünenthal, Xenon Pharmaceuticals, and NIH will share insights shaping the next generation of non-opioid therapeutics.

8th RNAi-Based Therapeutics Summit 2026

27th January 2027 - 29th January 2027

The 8th RNAi-Based Therapeutics Summit is the leading industry forum dedicated to advancing RNA interference therapies from discovery through clinical development.

Bringing together experts from across pharma, biotech, and academia, the summit focuses on addressing the most pressing challenges impacting the next generation of RNAi drugs.

Key discussions will explore extrahepatic delivery, novel RNAi chemistry, target selection, manufacturability, translational development, and clinical progress across a range of therapeutic areas.

With a strong emphasis on practical learning, attendees will benefit from interactive workshops, real-world case studies, and in-depth scientific discussions designed to support the development of safer, more effective RNAi therapeutics.

The summit offers unparalleled opportunities to network with industry leaders and stay ahead of the rapidly evolving RNAi landscape.

5th Nasal Formulation & Delivery Summit 2027

02nd February 2027 - 04th February 2027

Navigate Drug-Device Compatibility, Predictive Clinical Translation, CMC, Regulatory Pathways for Combination Products, & Investment Strategy to Advance Best in Class Intranasal Delivery

Intranasal delivery is at a tipping point. The first approved nose-to-brain therapy has validated the approach, while easier administration, delivery efficiency, and lifecycle management opportunities are driving investment across multiple therapeutic areas.

With a growing wave of innovative biotechs reporting promising clinical results and the industry anticipating its next landmark approval, intranasal drug delivery has never offered greater opportunity or excitement.

The 5th Nasal Formulation & Delivery Summit is uniting leading biotechs, pharma, and investors to optimize drug and device compatibility, overcome challenges in formulation, and navigate commercial strategy and investment to optimize efficient drug delivery.

From optimizing nose-to-brain delivery and improving bioavailability to navigating funding opportunities, join 70+ CEOs, CSOs, and Heads of R&D, Formulation, and CMC to advance intranasal treatment for CNS, emergency-use, neurological, and infectious diseases for patient efficacy.

S&OP and Integrated Business Planning Excellence for Life Sciences 2027

23rd February 2027 - 24th February 2027

The Marcus Evans S&OP and Integrated Business Planning Excellence for Life Sciences conference will bring together pharmaceutical and medical device leaders to explore how organizations are evolving S&OP and IBP to address increasing supply chain complexity, market volatility, and changing business demands.

Through practical case studies, attendees will examine approaches to advancing S&OP maturity, improving demand signals, and strengthening scenario planning.

Sessions will focus on how organizations are embedding S&OP and IBP as a strategic enterprise-wide mechanism and leveraging AI to strengthen decision-making across functions.

Speakers include senior leaders from Johnson & Johnson Innovative Medicine, Novartis, GE Healthcare, Gilead Sciences, Bristol Myers Squibb, Galderma, Bayer and many more!

BioPharma Asia readers can benefit from a €200 discount! Enquire on our website for more registration information.

TIDES Asia 2027

24th February 2027 - 26th February 2027

TIDES Asia is Asia’s premier biopharmaceutical conference focused on advancing oligonucleotide and peptide therapeutics.

It brings together 375+ attendees, 60+ industry speakers, and 40+ sponsors to share cutting-edge strategies in discovery, development, CMC, mRNA therapeutics, and genome editing.

The event features 2 workshops and 2 specialized tracks for the Asia-Pacific region.

World EPA Congress Europe 2027

02nd March 2027 - 03rd March 2027

The World Evidence, Pricing and Access (World EPA) Congress Europe 2027 will take place from March 2–3, 2027, at the RAI Congress Centre in Amsterdam.

As Europe’s largest annual gathering for market access, pricing, and health economics, the congress will feature over 1,600 delegates, 250 expert speakers, and 120 exhibitors.

Spanning 10 focused content tracks, the event addresses critical topics including healthcare reimbursement, rare diseases, HTA/payer dynamics, digital transformation, and real-world evidence.

Global pharmaceutical leaders and policymakers will convene to share cutting-edge strategies, optimize launch pathways, and explore innovative funding models to ensure sustainable patient access to medical innovation.

World Vaccine Congress Washington 2027

08th March 2027 - 11th March 2027

The World Vaccine Congress Washington 2027 returns March 8 – 11 at the Walter E. Washington Convention Center. As the most established global vaccine event, it covers the entire value chain from basic research to commercial manufacture.

The congress will gather 3,000 senior industry experts, 400 leading speakers, and 200 innovative exhibitors to drive progress in global health.

Key tracks include pandemic preparedness, clinical trials, bioprocessing, cancer immunotherapy, and equitable vaccine access.

Attendees will experience top presentations, strategic panel debates, and extensive networking opportunities. Join science, government, and manufacturing leaders to help shape the future of global disease eradication worldwide.

Gain an exclusive extra 20% off with code BPA20

17th World ADC London 2027

08th March 2027 - 11th March 2027

The 17th World ADC London will showcase the latest scientific advances and strategic developments shaping the next generation of antibody-drug conjugates.

Taking place from 8-11 March 2027, the event will unite 700+ ADC leaders, with a global faculty of 110 speakers from across Europe, North America and Asia bringing diverse perspectives on ADC innovation and development.

With ADC developers focused on achieving greater differentiation, the programme will explore novel cytotoxic and non-cytotoxic payloads, dual-payload ADCs and bispecific ADCs, alongside strategies to move beyond validated payloads and targets and overcome resistance mechanisms.

Covering the full development pathway, attendees will gain access to data-driven presentations, case studies and practical insights spanning discovery, preclinical and translational development, clinical development, process and analytical development, and manufacturing.

Explore the programme to discover the science, strategies and innovations shaping the future of ADC development.

2nd Edition S&OP and Integrated Business Planning Excellence for Pharma and Life Sciences conference 2027

15th March 2027 - 16th March 2027

The Marcus Evans 2^nd Edition S&OP and Integrated Business Planning Excellence for Pharma and Life Sciences conference will share case studies from leading pharmaceutical and medical device companies to advance S&OP maturity, strengthen planning agility and discuss AI implementations within planning workflows.

Sessions will move beyond theory and cover how professionals are navigating scenario planning and evolving demand and supply capabilities to ensure S&OP and IBP drive decision-making throughout the organisation.

Speakers include senior leaders from bioMérieux, Merck Life Science, Johnson & Johnson Innovative Medicine, Medtronic, Getinge, STADA, and many more!

BioPharma Asia readers can benefit from a €200 discount! Enquire on our website for more registration information.

13th American Biomanufacturing Summit 2027

08th April 2027 - 09th April 2027

The American Biomanufacturing Summit is taking place April 8-9, 2027 in San Francisco, CA. The summit brings together over 250 biopharma and biotech executive leaders for 2 days of sessions, workshops, and networking.

With sessions led by top biotech executives, the agenda is designed to discuss current trends, strategic insights, and best practices in key topics like manufacturing, cell and gene therapy, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics.

Network with your fellow biopharma leaders as we explore strategies to maximize efficiency while remaining compliant within the biomanufacturing space.

TIDES USA 2027

26th April 2027 - 29th April 2027

TIDES USA is a leading conference held in Boston dedicated to oligonucleotide and peptide therapeutics.

With 2000+ attendees, 200+ industry speakers, and 170+ sponsors, it covers research, development, manufacturing, drug delivery innovations, and regulatory considerations.

The event offers 8 workshops and 5 tracks, providing extensive networking opportunities for life sciences professionals.

ChinaBio 2027

27th April 2027 - 29th April 2027

ChinaBio™ is the meeting place for China’s life science leaders. The premier platform connecting the country’s biopharma ecosystem to do business, drive innovation, and navigate its rapidly evolving landscape.

Spanning the full value chain, from drug discovery and clinical development to manufacturing and commercialisation, ChinaBio™ brings together six specialist summits that explore breakthrough modalities, investment strategies, and the science shaping biotech’s future.

It unites the wider ecosystem in one environment, enabling connections across disciplines, companies, and development stages that go beyond any single specialist field.

Now expanded with specialized summits, ChinaBio™ offers a more comprehensive experience than ever, uniting innovation, partnership, and growth across China’s biopharma landscape.

Antibody & ADC Summit at ChinaBio™ 2027

27th April 2027 - 29th April 2027

From the minds behind the Antibody Engineering & Therapeutics series, the Antibody & ADC Summit at ChinaBio® brings two days of breakthrough science, strategic connections, and game-changing opportunities to Shanghai.

This dedicated track unites China’s most dynamic antibody and ADC innovation ecosystem, spotlighting the cutting-edge engineering, novel formats, and next-generation payload and linker technologies driving the field forward.

From early-stage discovery to clinical translation, attendees will dive deep into the science shaping the future of antibody-based therapeutics, including bispecifics, multispecifics, and antibody-drug conjugates.

Beyond the science, the summit creates a focused environment for dealmaking and collaboration, connecting biotech innovators, pharma leaders, investors, and CDMOs who are shaping this fast-moving space.

This is where China’s antibody and ADC community comes together to build the partnerships that will define the next wave of breakthroughs.

BioProcess International at ChinaBio™ 2027

27th April 2027 - 29th April 2027

Description: As China’s biopharma innovation accelerates, the path from discovery to patient depends on manufacturing.

The BioProcess International track at ChinaBio™ puts bioprocessing, CMC, and manufacturing strategy at the center of the conversation, right alongside the R&D leaders whose breakthroughs depend on it.

With the discovery and clinical pioneers driving China’s next generation of therapies in the room, this is where the critical questions get answered: how to scale novel modalities from bench to commercial supply, how CDMOs and biopharma companies are reshaping partnership models, and how manufacturing innovation is becoming a true competitive differentiator rather than a downstream afterthought.

ChinaBio™ Partnering Forum 2027

27th April 2027 - 29th April 2027

The ChinaBio™ Partnering Forum expands into two dedicated tracks, Partnering and Investment, bringing biotech, pharma, investors, and strategic partners together to explore the forces shaping China’s next phase of global growth.

The Partnering track dives into cross-border dealmaking, new deal structures, co-development models, NewCos, and what global pharma is really looking for as China becomes a major source of innovation.

The Investment track examines where capital is flowing, from venture and private funding to public markets and licensing income, alongside the rise of AI-native biotech as a new company-building and investment model.

Together, these tracks connect the dots between China’s innovation engine and the global capital and partnership opportunities it’s unlocking.

Cell & Gene Therapy Summit at ChinaBio™ 2027

27th April 2027 - 29th April 2027

Unlocking China’s cell & gene innovation, the Cell & Gene Therapy Summit connects China’s advanced therapies ecosystem with global life science leaders as part of ChinaBio™’s expanded content summits.

Backed by over a decade of experience hosting premier cell and gene therapy events across the US and Europe, attracting 1,500+ attendees annually, Cell & Gene Therapy International brings that expertise to China.

Following the remarkable success of its 2026 debut, this year’s summit expands its commitment to fostering collaboration among top researchers, biopharmaceutical leaders, and industry pioneers.

With a focus on cutting-edge R&D, manufacturing excellence, and strategic partnerships, attendees will gain unparalleled insight into breakthrough methodologies spanning cell therapies, gene editing platforms, viral vector technologies, and the full discovery-to-clinic continuum.

Nucleic Acids & Peptides Summit at ChinaBio™ 2027

27th April 2027 - 29th April 2027

The Nucleic Acids & Peptides Summit at ChinaBio™ is China’s premier gathering for the nucleic acid and peptide therapeutics community, connecting domestic innovators, global partners, and regulatory experts advancing mRNA, siRNA, ASOs, RNA editing, peptides, peptide-drug conjugates, and next-generation oral peptides.

Built on the proven pedigree of RNA Leaders and TIDES, the summit brings world-class content and unparalleled networking to China’s biotech hub.

Attendees will engage directly with leading Chinese biotech companies, research institutions, CDMOs, and investors driving breakthroughs in RNA and peptide modalities, while gaining insight from NMPA experts on regulatory pathways, manufacturing requirements, and commercialization strategies specific to China’s market.

As China’s biopharma landscape rapidly advances across oligonucleotides, peptides, mRNA, genome editing, and drug delivery, this summit bridges regional innovation with global opportunity, forging the partnerships that will translate next-generation modalities from discovery to commercialization.

European Pharma Outsourcing Summit 2027

13th May 2027 - 14th May 2027

The European Pharma Outsourcing Summit is taking place May 13-14, 2027 in Dusseldorf, Germany.

This executive pharma conference is tailored to provide executives from pharmaceutical companies with the latest innovations, strategic insights, and best practices.

Key focus areas include pharma outsourcing trends, contract manufacturing, pharmaceutical outsourcing, pharma supply chain optimization, pharma automation, pharma compliance, and regulatory in the pharmaceutical industry.

World EPA Congress USA 2027

14th September 2027 - 15th September 2027

The World Evidence, Pricing and Access Congress USA officially launches September 14–15, 2027, in Boston, establishing America’s leading forum for pharma, biotechs, payers, and HTA bodies.

This inaugural event tackles the critical friction points in healthcare delivery: balancing innovative therapy costs with sustainable patient access. Attendees will dive into real-world evidence (RWE) integration, navigating complex US pricing frameworks, and optimizing global market entry strategies.

Featuring interactive panels and presentation tracks, extensive solution-provider exhibitions, and limitless networking opportunities across two full days, the congress bridges the gap between clinical data and commercial viability – shaping the future of equitable, evidence-based healthcare access.